Skip to Main Content

Author Details

Melissa M Coughlin
Centers for Disease Control and Prevention
2006
28
16
PMIDPaper TitleJournal TitlePublished Year
36895677Lessons learned from the implementation of integrated serosurveillance of communicable diseases in the Americas.Rev Panam Salud Publica2023
37736039Characterizing infection of B cells with wild-type and vaccine strains of measles virus.iScience2023
36992247Tetanus and Diphtheria Seroprotection among Children Younger Than 15 Years in Nigeria, 2018: Who Are the Unprotected Children?Vaccines (Basel)2023
37262007Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status - United States, April 2021-September 2022.MMWR Morb Mortal Wkly Rep2023
34802478Descriptive evaluation of antibody responses to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in plasma and gingival crevicular fluid in a nursing home cohort-Arkansas, June-August 2020.Infect Control Hosp Epidemiol2022
35895418Performance of SARS-CoV-2 Antigens in a Multiplex Bead Assay for Integrated Serological Surveillance of Neglected Tropical and Other Diseases.Am J Trop Med Hyg2022
33395380Rapid Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Detention Facility, Louisiana, USA, May-June, 2020.Emerg Infect Dis2021
33731416Development of a Measles and Rubella Multiplex Bead Serological Assay for Assessing Population Immunity.J Clin Microbiol2021
33693830Shedding of Culturable Virus, Seroconversion, and 6-Month Follow-up Antibody Responses in the First 14 Confirmed Cases of Coronavirus Disease 2019 in the United States.J Infect Dis2021
33723510Infectious Period of Severe Acute Respiratory Syndrome Coronavirus 2 in 17 Nursing Home Residents-Arkansas, June-August 2020.Open Forum Infect Dis2021
32881855Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020.MMWR Morb Mortal Wkly Rep2020
33237893Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network - 12 States, April-August 2020.MMWR Morb Mortal Wkly Rep2020
32940635Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee.JAMA2020
28982603In vitro infectivity of oncolytic Newcastle Disease Virus: Correlation between plaque and fluorescent focus assays.J Virol Methods2018
29456016Monoclonal antibody based in vitro potency assay as a predictor of antigenic integrity and in vivo immunogenicity of a Respiratory Syncytial Virus post-fusion F-protein based vaccine.Vaccine2018
28106841Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies.Viruses2017
26192359Effect of jet injection on infectivity of measles, mumps, and rubella vaccine in a bench model.Vaccine2015
23280948Contribution of dendritic cells to measles virus induced immunosuppression.Rev Med Virol2013
21905149Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential.Rev Med Virol2012
23185609Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing.PLoS One2012
21787825Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine.Vaccine2011
19748648Human monoclonal antibodies to SARS-coronavirus inhibit infection by different mechanisms.Virology2009
19645480Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors for the severe acute respiratory syndrome-coronavirus papain-like protease.J Med Chem2009
18796354Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors.Bioorg Med Chem Lett2008
18852458A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication.Proc Natl Acad Sci U S A2008
17161858Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse.Virology2007
16864705Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo.Pediatr Res2006
16849509The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn.J Immunol2006
  • 1 - 28 of 28

Recommended Authors

Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai New York
Career Start Year 2015
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2014
Number of shared co-authors 0
Washington University School of Medicine
Career Start Year 2013
Number of shared co-authors 2
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Career Start Year 2013
Number of shared co-authors 0
Emory University School of Medicinegrid.471395.d
Career Start Year 2013
Number of shared co-authors 16
University of Maryland School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Rockefeller University
Career Start Year 2011
Number of shared co-authors 0
University of Texas Medical Branch
Career Start Year 2010
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2005
Number of shared co-authors 7
National Center for Toxicological Research
Career Start Year 2005
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 10
National Institute of Allergy and Infectious Disease, National Institute of Health
Career Start Year 2003
Number of shared co-authors 0
University of North Carolina at Chapel Hill
Career Start Year 2003
Number of shared co-authors 1
The Rockefeller University
Career Start Year 2002
Number of shared co-authors 0
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year 2002
Number of shared co-authors 1
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 0
Infectious Disease Clinical Research Program, Uniformed Services University
Career Start Year 2000
Number of shared co-authors 0
University of Texas Medical Branch
Career Start Year 1997
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 1995
Number of shared co-authors 27
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 0
Saint Louis University School of Medicine
Career Start Year 1992
Number of shared co-authors 0
Center for Vaccines and Immunology, University of Georgia
Career Start Year 1991
Number of shared co-authors 0
The University of Texas Medical Branch
Career Start Year 1991
Number of shared co-authors 0
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 1
Mayo Clinic Vaccine Research Group
Career Start Year 1985
Number of shared co-authors 3
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 2
University of North Carolina
Career Start Year 1981
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 1975
Number of shared co-authors 11

Collaborators

Centers for Disease Control and Prevention (CDC)
Co-authored papers 7
Vanderbilt University Medical Center
Co-authored papers 3
Vanderbilt University Medical Center
Co-authored papers 3
Centers for Disease Control and Prevention
Co-authored papers 3
US Centers for Disease Control and Prevention
Co-authored papers 3
Vanderbilt University Medical Center
Co-authored papers 3
Vanderbilt University Medical Center
Co-authored papers 2
Wake Forest University
Co-authored papers 2
Ohio State University Wexner Medical Center
Co-authored papers 2
Beth Israel Deaconess Medical Center
Co-authored papers 2
Wake Forest University
Co-authored papers 2
Albert Einstein College of Medicine
Co-authored papers 2
University of California los angeles
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Intermountain Medical Center and the University of Utah
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Centers for Disease Control and Prevention
Co-authored papers 2
Intermountain Medical Center and University of Utah
Co-authored papers 2
Montefiore Medical Center, Albert Einstein College of Medicine
Co-authored papers 2
Oregon Health and Science University
Co-authored papers 2
Centers for Disease Control and Prevention
Co-authored papers 2
University of Massachusetts Medical School - Baystate
Co-authored papers 2
US Centers for Disease Control and Prevention COVID-19 Response Team
Co-authored papers 2
Centers for Disease Control and Prevention
Co-authored papers 2
University of Colorado School of Medicine
Co-authored papers 2
University of Washington
Co-authored papers 2
Duke University
Co-authored papers 2
Johns Hopkins University
Co-authored papers 2
Hennepin County Medical Center
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2